Resources developed by IAS and its member societies
Imaging
Video Resource
Leading Insights: A Conversation with Professors Jessica M. Peña and Alexander van Rosendael
Watch the newest episode of IAS’ Leading Insights series to learn from Prof. Jessica M. Peña and Prof. Alexander van Rosendael as they discuss the latest study findings using CONFIRM2, the largest registry of quantification of atherosclerosis. IAS received an unrestricted grant from Cleerly to develop this resource. About Leading InsightsLeading Insights is a video series in which IAS’ global experts discuss recent research findings about breakthrough diagnostic tools, therapies and devices relevant to the diagnosis and management of […]
Understanding the Prognostic Value of AI-Based Quantitative Coronary CT
Artificial Intelligence Quantitative Computed Tomography (AI-QCT) uses AI technology to analyze the amount, composition, and stenosis of coronary artery plaque. IAS received an unrestricted grant from Cleerly to develop this resource.
This first graphic explains the formation of triglycerides and how their concentration in blood serves as a biomarker for TGRL, which promote the formation of atheroma.
Cleerly, the International Atherosclerosis Society, and Women As One, in collaboration with the Baim Institute for Clinical Research, have produced a webinar series designed to change how healthcare providers understand, detect, and manage coronary artery disease by going beyond symptoms and stenosis to the true biology of atherosclerosis. Episode 1: Atherosclerosis: Basic Concepts and Current Understanding Presented by […]
The Brussels International Declaration on Lipoprotein(a) Testing and Management
The Brussels International Declaration on Lp(a) Testing and Management was co-created by the Lp(a) International Task Force and global leaders at the Lp(a) Global Summit, held in Brussels, Belgium, on March 24–25, 2025. The event, organized by FH Europe Foundation, brought together scientific experts, people with the lived experience of elevated Lp(a) and policy makers from the European Institutions and World Health Organization. The World Heart Federation, Global Heart Hub, and European Alliance for Cardiovascular Health and scientific organizations such as European Atherosclerosis Society, and International Atherosclerosis Society were formal partners.
Frequency of Residual Combined Dyslipidemia and Hypertriglyceridemia in Patients with Coronary Heart Disease in 13 Countries Across 6 WHO Regions: Results from INTERASPIRE
Hypertriglyceridemia (HTG) is independently associated with risk of atherosclerotic events, even when LDL-cholesterol levels appear controlled. This INTERASPIRE study determined the frequency of HTG and residual combined dyslipidemia and their related factors in patients with coronary heart disease (CHD) from 13 countries across six World Health Organization (WHO) regions.
Training Modules for Management of HeFH in Children
The aims of these two modules are to provide paediatricians and other health care professionals with information to help them in the identification and management of children and young people who have heterozygous familial hypercholesterolaemia. The modules are free to access and are made available by IAS partner, Royal College of Paediatrics and Child Health.
